Evidence map›Paper›PMID 23914259›Full record

ReviewTranslational stroke research2013

Preconditioning strategy in stem cell transplantation therapy.

Shan Ping Yu, Zheng Wei, Ling Wei

Open access · greenAbstract readReview
In one paragraph

Review in Translational stroke research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 3 pooled it
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 3 syntheses or guidelines pooled it, 186 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Article
  8. Combined nonmyeloablative total lymphoid irradiation and low-dose total body irradiation enhances donor chimerism and leads to islet allograft acceptance.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Exosomes for angiogenesis induction in ischemic disorders.Journal of cellular and molecular medicine · 2023
    Review
  20. Review

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Shan Ping YuDepartment of Anesthesiology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Zheng Wei
Ling Wei
Peking University · CNEmory University · US

Funding

Transplantation of Pre-conditioned Bone Marrow Mesenchymal Stem Cells after IscheR01NS062097 · NINDS · EMORY UNIVERSITY · PI WEI, LING · 2010 to 2014
$1.7M
Angiogenesis, Functional Recovery and TNF-alpha after StrokeR01NS045810 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WEI, LING · 2004 to 2008
$1.3M
Combination therapy in human ES cell transplantation after neonatal strokeR01NS058710 · NINDS · EMORY UNIVERSITY · PI WEI, LING · 2009 to 2012
$1.3M
FUNCTION RESTORATION BY ES CELL IMPLANT AFTER ISCHEMIAR01NS045155 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WEI, LING · 2003 to 2006
$1.2M
Neuroprotection NR3A in Cultured Neurons and Ischemic NeonatesR01NS057255 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YU, SHAN P. · 2007 to 2011
$1.1M
Promoting axonal growth and tissue repair in stem cell therapy after strokeR21NS075338 · NINDS · EMORY UNIVERSITY · PI WEI, LING · 2011 to 2012
$426k
NINDS NIH HHS NS057255NINDS NIH HHS NS058710NINDS NIH HHS NS062097NINDS NIH HHS R01 NS045155NINDS NIH HHS R01 NS045810NINDS NIH HHS R01 NS057255NINDS NIH HHS R01 NS058710NINDS NIH HHS R01 NS062097NINDS NIH HHS R21 NS075338
6 · The paper itself

Abstract

Stem cell transplantation therapy has emerged as a promising regenerative medicine for ischemic stroke and other neurodegenerative disorders. However, many issues and problems remain to be resolved before successful clinical applications of the cell-based therapy. To this end, some recent investigations have sought to benefit from well-known mechanisms of ischemic/hypoxic preconditioning. Ischemic/hypoxic preconditioning activates endogenous defense mechanisms that show marked protective effects against multiple insults found in ischemic stroke and other acute attacks. As in many other cell types, a sub-lethal hypoxic exposure significantly increases the tolerance and regenerative properties of stem cells and progenitor cells. So far, a variety of preconditioning triggers have been tested on different stem cells and progenitor cells. Preconditioned stem cells and progenitors generally show much better cell survival, increased neuronal differentiation, enhanced paracrine effects leading to increased trophic support, and improved homing to the lesion site. Transplantation of preconditioned cells helps to suppress inflammatory factors and immune responses, and promote functional recovery. Although the preconditioning strategy in stem cell therapy is still an emerging research area, accumulating information from reports over the last few years already indicates it as an attractive, if not essential, prerequisite for transplanted cells. It is expected that stem cell preconditioning and its clinical applications will attract more attention in both the basic research field of preconditioning as well as in the field of stem cell translational research. This review summarizes the most important findings in this active research area, covering the preconditioning triggers, potential mechanisms, mediators, and functional benefits for stem cell transplant therapy.

Indexed as

Ischemic PreconditioningStem Cell TransplantationAnimalsBrainBrain InfarctionHumansMiceMitochondriaRatsSignal TransductionHeart attackIschemiaNeurodegenerative disorderStem cell preconditioningStroke

Identifiers

PMID23914259
PMCPMC3728897
OpenAlexW1992074285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.